Bergamo, Italy

Giangiacomo Torri

This inventor holds 4 USPTO granted patents. Top assignees: Crinos Industria Farmabiologica, S.p.a., Crinos Industria Farmacobiologica S.p.a., Sanofi. Active years: 1983-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giangiacomo Torri. Retrieved from https://idiyas.com/inventor/giangiacomo-torri-2cc97yv2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 1983-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Giangiacomo Torri

Introduction

Giangiacomo Torri, based in Bergamo, Italy, is an accomplished inventor recognized for his significant contributions to the field of polysaccharide chemistry. With a portfolio of four patents, his work primarily focuses on processes that enhance the utility of polysaccharides through innovative chemical methods.

Latest Patents

Among his notable patents, two stand out for their groundbreaking approaches to depolymerization and sulfation of polysaccharides. The first patent details a process for the depolymerization and sulfation of polysaccharides, utilizing a sulfuric acid and chlorosulfonic acid mixture. This innovative technique opens new avenues for improving polysaccharide derivatives.

The second patent showcases a novel depolymerized and supersulfated heparin, characterized by a molecular weight between 2000 and 9000, along with a sulfation degree of at least 2.5. This invention highlights the sulfation of all primary hydroxy groups and describes a preparation process using a natural-origin heparin or its fractions with sulfuric acid and chlorosulfonic acid. The resulting pharmaceutical compositions containing this heparin have potential antithrombotic, hypolipemic, and fibrinolytic activities. These advancements hold promise for preventing thrombosis and treating atherosclerosis.

Career Highlights

Giangiacomo Torri has had a distinguished career, with experience at several prestigious companies, including Sclavo, Inc. and Sanofi. His work at these organizations has been instrumental in bridging the gap between innovative research and practical applications in the pharmaceutical industry, enabling the advancement of new therapeutic solutions.

Collaborations

Throughout his career, Torri has collaborated with esteemed professionals, including Annamaria Naggi and Benito Casu. These collaborations have contributed to the depth and breadth of his research, further solidifying his reputation in the field of polysaccharide chemistry.

Conclusion

Giangiacomo Torri's inventive spirit and dedication to advancing polysaccharide applications have earned him a prominent position among innovators in the scientific community. His patents not only showcase his expertise but also pave the way for future research in pharmacological applications, highlighting the critical role of innovation in addressing health challenges. Torri's journey is a testament to the importance of combining scientific inquiry with practical applications, ultimately leading to impactful advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…